Related Experiment Video
Updated: Nov 15, 2025
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Cytocompatibility, membrane disruption, and siRNA delivery using environmentally responsive cationic nanogels.
David S Spencer1, Aaliyah B Shodeinde1, David W Beckman2
1McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX 78712, USA.
Environmentally responsive hydrogels offer a promising solution for safe and effective delivery of nucleic acid therapies. Researchers developed and tested nanoparticle formulations, identifying successful candidates with low toxicity and high gene-silencing efficacy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Nucleic acid-based therapeutics show promise for treating various diseases.
- Clinical translation is limited by challenges in safe, controlled delivery.
- Environmentally responsive hydrogels are potential carriers for nucleic acid delivery.
Purpose of the Study:
- To assess nanoparticle formulations for safe and effective small interfering RNA (siRNA) delivery.
- To evaluate in vitro toxicity, hemolytic capacity, siRNA loading, and gene-silencing efficacy of developed nanoparticles.
Main Methods:
- Synthesis of nanoparticle formulations with controlled pKa, swelling, and surface PEG density.
- In vitro assessment of nanoparticle toxicity and hemolytic activity.
- Evaluation of siRNA loading capacity and gene-silencing efficiency.
Main Results:
- Successful nanoparticle candidates demonstrated low cytotoxicity and pH-dependent membrane disruption.
- Optimal formulations exhibited high siRNA loading capacity.
- The most effective candidates achieved high transfection and gene-silencing efficacies.
Conclusions:
- Environmentally responsive hydrogel nanoparticles are effective carriers for siRNA delivery.
- Tailored nanoparticle properties are crucial for achieving low toxicity and high therapeutic efficacy.
- These findings support the potential of these nanoparticles for advancing nucleic acid-based therapies.
